MRI Systems in Minnesota

IMRIS is a global leader in intraoperative MRI imaging solutions, specializing in fully integrated hybrid operating suites for image-guided neurosurgery. Founded in 2005 from research at Canada's National Research Council and headquartered in Chaska, Minnesota, IMRIS designs, manufactures, and deploys movable intraoperative MRI systems that enable real-time imaging during surgical procedures without patient relocation. The flagship product, the IMRIS Surgical Theatre, features a ceiling-mounted rail system that transports the MRI scanner between a diagnostic imaging room and adjacent operating rooms, bringing imaging directly to the surgical field. This innovation enhances precision in minimally invasive neurosurgical interventions and has benefited over 70,000 patients worldwide across more than 100 hospitals and cancer centers. The company holds 30 patents related to MRI-guided procedures and provides comprehensive services including customized surgical suite design, installation, clinical training, and ongoing support. IMRIS also offers image-guided surgical robotics and works in partnership with industry leaders to deliver integrated intraoperative imaging products.

Resoundant, Inc. develops and delivers Magnetic Resonance Elastography (MRE), a quantitative, noninvasive imaging technology for liver fibrosis assessment and staging of liver disease. MRE converts MRI data into precise, reproducible measurements of tissue stiffness using advanced computational algorithms to generate standardized biomarkers, offering an FDA-cleared alternative to Fibroscan transient elastography and shear wave ultrasound elastography. The technology is deployed as an upgrade to existing MRI systems and is available at thousands of radiology and imaging centers globally. MRE provides consistent, operator-independent, scanner-independent clinical assessment and has been accepted into the FDA Biomarker Qualification Program as a Reasonably Likely Surrogate Endpoint for MASH (Metabolic Associated Fatty Liver Disease) clinical trials. The company serves healthcare systems, radiology centers, and imaging facilities worldwide seeking noninvasive, quantitative liver disease assessment capabilities.